Prognostic value of aspartyl (asparaginyl)-β-hydroxylase/humbug expression in non–small cell lung carcinoma

Despite improvements in the detection and use of biomarkers, including epidermal growth factor receptor, ERCC1, and p16, the 5-year survival rate with non–small cell lung cancer remains at 15%. This suggests that additional biomarkers are needed to better prognosticate clinical course and guide ther...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Luu, Martin, Sabo, Edmond, de la Monte, Suzanne M., Greaves, Wesley, Wang, JiYi, Tavares, Rosemarie, Simao, Lelia, Wands, Jack R., Resnick, Murray B., Wang, LiJuan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2893029/
https://ncbi.nlm.nih.gov/pubmed/19200576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2008.11.001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia